M Bares, I Rektorová, L Krajcovicová, I Rektor. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antiparkinson Agents/administration & dosageAntiparkinson Agents/adverse effectsAntiparkinson Agents/therapeutic useBenzothiazoles/administration & dosageBenzothiazoles/adverse effectsBenzothiazoles/therapeutic useDopamine Agonists/administration & dosageDopamine Agonists/adverse effectsDopamine Agonists/therapeutic useEchocardiographyFemaleHeart Valve Diseases/chemically inducedHeart Valves/drug effectsHumansIndoles/administration & dosageIndoles/adverse effectsIndoles/therapeutic useLevodopa/administration & dosageLevodopa/adverse effectsLevodopa/therapeutic useMaleMiddle AgedParkinson Disease/drug therapyParkinson Disease/physiopathologyPergolide/administration & dosagePergolide/adverse effectsPergolide/therapeutic usePramipexole
Substances: See more » Antiparkinson AgentsBenzothiazolesDopamine AgonistsIndolesropinirolePergolideLevodopaPramipexole
Year: 2008 PMID: 18758889 DOI: 10.1007/s00415-008-0972-x
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849